| HD |
HD, IT15: Huntingtin |
KPNA2 |
KPNA2, RCH1, SRP1: Importin subunit alpha-2 |
15.150 |
Evidence |
|
| RGS2 |
RGS2, G0S8: Regulator of G-protein signaling 2 |
COPA |
COPA: Coatomer subunit alpha |
15.150 |
Evidence |
|
| EPOR |
EPOR: Erythropoietin receptor precursor |
MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
15.150 |
Evidence |
|
| UBTF |
UBTF, UBF, UBF1: Nucleolar transcription factor 1 |
SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
15.150 |
Evidence |
|
| MGMT |
MGMT: Methylated-DNA--protein-cysteine methyltransferase |
MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
15.150 |
Evidence |
|
| CD44 |
IPI00305064 |
MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
15.150 |
Evidence |
|
| MYB |
MYB: Myb proto-oncogene protein |
TCF3 |
TCF3, E2A, ITF1: Transcription factor E2-alpha |
15.150 |
Evidence |
|
| RB1 |
RB1: Retinoblastoma-associated protein |
MAP2K1 |
MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 |
15.150 |
Evidence |
|
| PRKCG |
PRKCG, PKCG: Protein kinase C gamma type |
YWHAH |
YWHAH, YWHA1: 14-3-3 protein eta |
15.150 |
Evidence |
|
| RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
MAP3K14 |
MAP3K14, NIK: Mitogen-activated protein kinase kinase kinase 14 |
15.150 |
Evidence |
|
| CFLAR |
CFLAR, CASH, CASP8AP1, CLARP, MRIT: CASP8 and FADD-like apoptosis regulator prec |
MAP2K1 |
MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 |
15.150 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
SHC3 |
SHC3, NSHC, SHCC: SHC-transforming protein 3 |
15.130 |
Evidence |
|
| NR1D1 |
NR1D1, EAR1, HREV, THRAL: Orphan nuclear receptor NR1D1 |
NR1D2 |
nuclear receptor subfamily 1, group D, member 2 |
15.130 |
Evidence |
|
| NR2F1 |
NR2F1, EAR3, ERBAL3, TFCOUP1: COUP transcription factor 1 |
NR1D2 |
nuclear receptor subfamily 1, group D, member 2 |
15.130 |
Evidence |
|
| PRKD3 |
PRKD3, EPK2, PRKCN: Serine/threonine-protein kinase D3 |
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
15.130 |
Evidence |
|
| PRKD3 |
PRKD3, EPK2, PRKCN: Serine/threonine-protein kinase D3 |
PRKCH |
PRKCH, PKCL, PRKCL: Protein kinase C eta type |
15.130 |
Evidence |
|
| DDX39 |
DDX39: ATP-dependent RNA helicase DDX39 |
PIAS1 |
PIAS1, DDXBP1: E3 SUMO-protein ligase PIAS1 |
15.130 |
Evidence |
|
| PSMC2 |
PSMC2, MSS1: 26S protease regulatory subunit 7 |
WBSCR1 |
EIF4H, KIAA0038, WBSCR1, WSCR1: Eukaryotic translation initiation factor 4H |
15.130 |
Evidence |
|
| GTF2F1 |
GTF2F1, RAP74: Transcription initiation factor IIF subunit alpha |
PSMC1 |
PSMC1: 26S protease regulatory subunit 4 |
15.130 |
Evidence |
|
| CAD |
CAD: CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase |
CDC6 |
CDC6, CDC18L: Cell division control protein 6 homolog |
15.130 |
Evidence |
|
| EEF1B2 |
EEF1B2, EEF1B, EF1B: Elongation factor 1-beta |
JARID1A |
JARID1A, RBBP2, RBP2: Histone demethylase JARID1A |
15.130 |
Evidence |
|
| EIF2S2 |
EIF2S2, EIF2B: Eukaryotic translation initiation factor 2 subunit 2 |
CCT2 |
CCT2, 99D8.1, CCTB: T-complex protein 1 subunit beta |
15.130 |
Evidence |
|
| CTPS |
CTPS: CTP synthase 1 |
EIF2S2 |
EIF2S2, EIF2B: Eukaryotic translation initiation factor 2 subunit 2 |
15.130 |
Evidence |
|
| FOS |
FOS, G0S7: Proto-oncogene protein c-fos |
HCK |
IPI00029769 |
15.130 |
Evidence |
|
| GSR |
GSR, GLUR, GRD1: Glutathione reductase, mitochondrial precursor |
MCM3 |
MCM3: DNA replication licensing factor MCM3 |
15.130 |
Evidence |
|